Status:
COMPLETED
CancerLife: Patient-Driven Solution in Cancer Care
Lead Sponsor:
Saint John's Cancer Institute
Collaborating Sponsors:
Healthy Platforms, LLC
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary purpose of this study is to evaluate the use of a digital information and communication platform (DICP) in improving outcomes in patients with cancer and their caregivers.
Detailed Description
This is a nonblinded, randomized, controlled trial of a digital information and communication platform (DICP) in self-reporting and monitoring of cancer and cancer-treatment related symptoms compared ...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Diagnosis of cancer
- Receiving systemic treatment (chemotherapy, biotherapy/immunotherapy, hormonal therapy) that is expected to continue for at least 3 treatment sessions (approximately 9 weeks) from the time of enrollment
- Karnofsky Index ≥50%
- Able to understand and sign informed consent
- Owns and able to use an electronic communication device (smart phone, tablet, laptop, desktop) and answer simple self-report questionnaires on their own
Exclusion
- Relevant cognitive impairment
- Participating in a therapeutic clinical trial
- Unable to read and comprehend English language text
Key Trial Info
Start Date :
March 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 7 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03371147
Start Date
March 15 2018
End Date
January 7 2020
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
John Wayne Cancer Institute at Providence Saint John's Health Center
Santa Monica, California, United States, 90404